ArticleThe Journal of pharmacology and experimental therapeutics2011

The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology.

Taiza H Figueiredo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.